PATH/Eric Becker
GHTC joins sign-on letter urging swift passage of FY20 appropriations bills to avoid negative consequences for science and research

GHTC joined 162 organizations in endorsing a letter to House and Senate leadership urging them to complete work on the fiscal year (FY) 2020 appropriations bills as soon as possible, given that the uncertainty created by short-term continuing resolutions can have “severe consequences for science and research.”


GHTC sends letter urging Congressional appropriators to include report language on BARDA in F20 bill

GHTC sent a letter to House and Senate appropriators urging them to include in the final fiscal year (FY) 2020 Labor, Health and Human Services, Education, and Related Agencies bill report language emphasizing the role of the Biomedical Advanced Research and Development Authority (BARDA) in advancing R&D for naturally-occurring health threats and requesting a delineation of BARDA’s investments in this area in its annual five-year budget plan. 


PATH/Gabe Bienczycki
GHTC responds to RFI on National Vaccine Action Plan

GHTC submitted comments to a US Department of Health and Human Services request for information (RFI) on the 2020 National Vaccine Action Plan (NVP). GHTC’s submission encouraged the continuation of R&D objectives reflected in the 2010 NVP and recommended additional areas of focus including strengthening public-private partnerships, advancing regulatory science, ensuring sustainable financing for areas that lack commercial market demand, promoting access-centered R&D, and collaborating with international partners to strengthen laboratory and clinical trial capacity.


All News


Breakthroughs Blog

GHTC in the Media

Advocacy Actions

Our members work to improve health worldwide